Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2024 Sep 16;109(10):2553-2560.
doi: 10.1210/clinem/dgae162.

Comparison of Normocalcemic vs Hypercalcemic Primary Hyperparathyroidism in a Hypercalciuric Renal Stone Population

Affiliations
Comparative Study

Comparison of Normocalcemic vs Hypercalcemic Primary Hyperparathyroidism in a Hypercalciuric Renal Stone Population

Caroline Halimi et al. J Clin Endocrinol Metab. .

Abstract

Context: Primary hyperparathyroidism (PHPT) is commonly diagnosed in the setting of hypercalcemia, whereas normocalcemic primary hyperparathyroidism (NHPT) may be misdiagnosed.

Objective: Our objective was to compare patients with hypercalcemic hyperparathyroidism (HPHPT) vs patients with NHPT hypercalciuric renal stones.

Methods: We took advantage of a routine calcium load test performed in patients with hypercalciuric renal stones to assess retrospectively among patients with PHPT the prevalence and characteristics of NHPT and HPHPT under a calcium-restricted diet.

Results: Among 1671 patients with hypercalciuria, 91 patients had a final diagnosis of PHPT (postload ionized calcium [iCa] > 1.31 mmol/L and parathyroid hormone [PTH] > 30 pg/mL). Prevalence of NHPT is 40% of all PHPT; however, according to total serum calcium, 4/35 NHPT and 7/56 HPHPT cases would have been misclassified in the other group. Eighteen of 35 NHPT and 40/56 HPHPT cases underwent parathyroidectomy. No significant characteristics relating to parathyroid weight, stone composition, or bone remodeling biomarkers were detected between groups. Although iCa is higher in HPHPT in the fasting state and after calcium load, we found no difference for calcium diet, 24-hour calciuria, or calcitriol. Renal calcium excretion postload increased by 303% in NHPT but only 176% in HPHPT (P = .01) likely explained by a lesser PTH decrease (P = .02). However, a strong negative association (P < .0001) detected between pooled preload and postload iCa and PTH only in the NHPT group suggests a persistent efficient PTH-CaSR control within the parathyroid glands in this group.

Conclusion: Our data show the relevance of dynamic tests to unmask NHPT in patients with hypercalciuric renal stones.

Keywords: CaSR; hypercalcemic primary hyperparathyroidism; hypercalciuria; normocalcemic primary hyperparathyroidism; primary hyperparathyroidism.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Flow chart. Among 1671 patients with hypercalciuria and renal stones referred to our department for a calcium load test over a 10 years. PHPT, primary hyperparathyroidism; NHPT, normocalcemic primary hyperparathyroidism; HPHPT, hypercalcemic primary hyperparathyroidism; PTX, parathyroidectomy.
Figure 2.
Figure 2.
Distribution of iCa in the studied population in a fasting state after (A) a calcium-restricted diet and (B) following a calcium load test. As shown, all patients experienced a postload iCa >1.31 mmol/L. Relationship between PTH and iCa (C) before and (D) after a calcium load test. Dotted lines represent the iCa normal upper limit. In (C) the solid line represents the serum PTH normal upper limit. In (D) the solid line represents serum the PTH upper limit in the context of hypercalcemia (see “Material and Methods”).
Figure 3.
Figure 3.
Comparison between NHPT and HPHPT groups of preload and postload total calcemia (A), iCA (B), PTH (C), and postload iCa, PTH FECa variation (D) (*P < 0.05). Results are expressed in percentage from baseline value (fasting value = 100%).
Figure 4.
Figure 4.
Association between iCa and serum PTH in NHPT (A) and HPHPT groups (B). Association between iCa and FECa in NHPT (C) and HPHPT groups (D). Patients’ preload and postload data are pooled.

References

    1. Bilezikian JP, Khan AA, Silverberg SJ, et al. Evaluation and management of primary hyperparathyroidism: summary statement and guidelines from the fifth international workshop. J Bone Miner Res. 2022;37(11):2293‐2314. - PubMed
    1. Bilezikian JP, Brandi ML, Eastell R, et al. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the fourth international workshop. J Clin Endocrinol Metab. 2014;99(10):3561‐3569. - PMC - PubMed
    1. Maruani G, Hertig A, Paillard M, Houillier P. Normocalcemic primary hyperparathyroidism: evidence for a generalized target-tissue resistance to parathyroid hormone. J Clin Endocrinol Metab. 2003;88(10):4641‐4648. - PubMed
    1. Siprova H, Frysak Z, Soucek M. Primary hyperparathyroidism, with a focus on management of the normocalcemic form: to treat or not to treat? Endocr Pract. 2016;22(3):294‐301. - PubMed
    1. Souberbielle JC, Cavalier E, Cormier C. How to manage an isolated elevated PTH? Ann Endocrinol (Paris). 2015;76(2):134‐141. - PubMed

Publication types